These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21801476)

  • 1. Effect of B-vitamins and n-3 PUFA supplementation for 5 years on blood pressure in patients with CVD.
    Szabo de Edelenyi F; Vergnaud AC; Ahluwalia N; Julia C; Hercberg S; Blacher J; Galan P
    Br J Nutr; 2012 Mar; 107(6):921-7. PubMed ID: 21801476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supplementation with B vitamins or n-3 fatty acids and depressive symptoms in cardiovascular disease survivors: ancillary findings from the SUpplementation with FOLate, vitamins B-6 and B-12 and/or OMega-3 fatty acids (SU.FOL.OM3) randomized trial.
    Andreeva VA; Galan P; Torrès M; Julia C; Hercberg S; Kesse-Guyot E
    Am J Clin Nutr; 2012 Jul; 96(1):208-14. PubMed ID: 22648722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B vitamin and/or ω-3 fatty acid supplementation and cancer: ancillary findings from the supplementation with folate, vitamins B6 and B12, and/or omega-3 fatty acids (SU.FOL.OM3) randomized trial.
    Andreeva VA; Touvier M; Kesse-Guyot E; Julia C; Galan P; Hercberg S
    Arch Intern Med; 2012 Apr; 172(7):540-7. PubMed ID: 22331983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MTHFR 677C → T genotype modulates the effect of a 5-year supplementation with B-vitamins on homocysteine concentration: The SU.FOL.OM3 randomized controlled trial.
    Fezeu LK; Ducros V; Guéant JL; Guilland JC; Andreeva VA; Hercberg S; Galan P
    PLoS One; 2018; 13(5):e0193352. PubMed ID: 29813097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial.
    Galan P; Kesse-Guyot E; Czernichow S; Briancon S; Blacher J; Hercberg S;
    BMJ; 2010 Nov; 341():c6273. PubMed ID: 21115589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel, multi-ingredient supplement to manage elevated blood lipids in patients with no evidence of cardiovascular disease: a pilot study.
    Hobbs T; Caso R; McMahon D; Nymark M
    Altern Ther Health Med; 2014; 20(5):18-23. PubMed ID: 25141367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of multivitamin supplementation on the homocysteine and methylmalonic acid blood concentrations in women over the age of 60 years.
    Wolters M; Hermann S; Hahn A
    Eur J Nutr; 2005 Mar; 44(3):183-92. PubMed ID: 15309436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a protective (synergistic?) effect of B-vitamins and omega-3 fatty acids on cardiovascular diseases.
    de Bree A; Mennen LI; Hercberg S; Galan P
    Eur J Clin Nutr; 2004 May; 58(5):732-44. PubMed ID: 15116076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Background and rationale of the SU.FOL.OM3 study: double-blind randomized placebo-controlled secondary prevention trial to test the impact of supplementation with folate, vitamin B6 and B12 and/or omega-3 fatty acids on the prevention of recurrent ischemic events in subjects with atherosclerosis in the coronary or cerebral arteries.
    Galan P; de Bree A; Mennen L; Potier de Courcy G; Preziozi P; Bertrais S; Castetbon K; Hercberg S
    J Nutr Health Aging; 2003; 7(6):428-35. PubMed ID: 14625623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-Arginine and B vitamins improve endothelial function in subjects with mild to moderate blood pressure elevation.
    Menzel D; Haller H; Wilhelm M; Robenek H
    Eur J Nutr; 2018 Mar; 57(2):557-568. PubMed ID: 27817128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular effects of B-vitamins and/or N-3 fatty acids: the SU.FOL.OM3 trial.
    Blacher J; Czernichow S; Paillard F; Ducimetiere P; Hercberg S; Galan P;
    Int J Cardiol; 2013 Jul; 167(2):508-13. PubMed ID: 22365647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory and cardioprotective effects of n-3 polyunsaturated fatty acids and plant sterols in hyperlipidemic individuals.
    Micallef MA; Garg ML
    Atherosclerosis; 2009 Jun; 204(2):476-82. PubMed ID: 18977480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of n-3 fatty acids on cognitive decline: a randomized, double-blind, placebo-controlled trial in stable myocardial infarction patients.
    Geleijnse JM; Giltay EJ; Kromhout D
    Alzheimers Dement; 2012 Jul; 8(4):278-87. PubMed ID: 21967845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of long-chain ω-3 fatty acids and lutein + zeaxanthin supplements on cardiovascular outcomes: results of the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
    ; Bonds DE; Harrington M; Worrall BB; Bertoni AG; Eaton CB; Hsia J; Robinson J; Clemons TE; Fine LJ; Chew EY
    JAMA Intern Med; 2014 May; 174(5):763-71. PubMed ID: 24638908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamins B(12), B(6), and folic acid for cognition in older men.
    Ford AH; Flicker L; Alfonso H; Thomas J; Clarnette R; Martins R; Almeida OP
    Neurology; 2010 Oct; 75(17):1540-7. PubMed ID: 20861451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DHA status influences effects of B-vitamin supplementation on cognitive ageing: a post-hoc analysis of the B-proof trial.
    van Soest APM; van de Rest O; Witkamp RF; Cederholm T; de Groot LCPGM
    Eur J Nutr; 2022 Oct; 61(7):3731-3739. PubMed ID: 35704085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of n-3 fatty acids on C-reactive protein levels in patients with chronic renal failure.
    Madsen T; Schmidt EB; Christensen JH
    J Ren Nutr; 2007 Jul; 17(4):258-63. PubMed ID: 17586424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial.
    Ebbing M; Bleie Ø; Ueland PM; Nordrehaug JE; Nilsen DW; Vollset SE; Refsum H; Pedersen EK; Nygård O
    JAMA; 2008 Aug; 300(7):795-804. PubMed ID: 18714059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No association between the intake of marine n-3 PUFA during the second trimester of pregnancy and factors associated with cardiometabolic risk in the 20-year-old offspring.
    Rytter D; Bech BH; Halldorsson T; Christensen JH; Schmidt EB; Danielsen I; Henriksen TB; Olsen SF
    Br J Nutr; 2013 Dec; 110(11):2037-46. PubMed ID: 23680230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of vitamin B-12 and n-3 polyunsaturated fatty acids on plasma homocysteine, ferritin, C-reaction protein, and other cardiovascular risk factors: a randomized controlled trial.
    Huang T; Li K; Asimi S; Chen Q; Li D
    Asia Pac J Clin Nutr; 2015; 24(3):403-11. PubMed ID: 26420180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.